GB10, a best-in-class antibody fusion protein targeting VEGF/Ang-2, exhibits promising therapeutic efficacy for neovascular eye diseases
用户3Lx0LvmkHW20
2个月前
62
10
已完结
1. 系统已在2025-12-16 17:20:58对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.21203/rs.3.rs-5135499/v1
文献链接: https://www.researchsquare.com/article/rs-5135499/v1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Xiling Wei; Yuxin Qiu; Wei Shang; Xiangling Zhang; Wenjie Yang; Chengyong Yang; Xi Chen; Huiming Li; Suofu Qin
